buthionine sulfoximine glutathione synthesis inhibitor Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma sulfoximine, an inhibitor of – The glutathione synthesis inhibitor buthionine
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF B and MAPK signaling pathways Full article: Redox enzyme networks shaping cancer drug metabolism and therapeutic resistance Depletion of cellular GSH by treatment with l Download Scientific Diagram
Pay in 4 interest-free payments of $5.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



